These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4041106)

  • 1. Estimation of the extent of platination and the sites of Pt binding after interaction of cis- and trans-diamminedichloroplatinum(II) with DNA and chromatin.
    Oliński R; Wiaderkiewicz R; Walter Z
    Acta Biochim Pol; 1985; 32(2):119-25. PubMed ID: 4041106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts.
    Roberts JJ; Friedlos F
    Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
    Lippert B
    Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstrand DNA-platinum-DNA/cross-links induced by cis- and trans-diamminedichloroplatinum(II) at elevated temperature.
    Kulamowicz I; Walter Z; Krupa R
    Acta Biochim Pol; 1990; 37(1):77-9. PubMed ID: 2087920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.
    Terheggen PM; Dijkman R; Begg AC; Dubbelman R; Floot BG; Hart AA; den Engelse L
    Cancer Res; 1988 Oct; 48(19):5597-603. PubMed ID: 3046743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity, tumorigenicity, and electrophilic reactivity of the stereoisomeric platinum(II) complexes of 1,2-diaminocyclohexane.
    Leopold WR; Batzinger RP; Miller EC; Miller JA; Earhart RH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4368-77. PubMed ID: 7030475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cis-diamminedichloroplatinum (II) on the formation of DNA-Pt-DNA cross-links.
    Walter Z; Spychała M
    Acta Biochim Pol; 1991; 38(1):95-9. PubMed ID: 1796714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophoretic analysis of DNA modifications induced by cis- and trans-diamminedichloroplatinum (II) during heat-denaturation of conformation isomers of pBR322 DNA.
    Rauko P; Hrubisko M; Hanusovská E
    Neoplasma; 1990; 37(2):131-8. PubMed ID: 2342628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction of DNA molecules with divalent platinum coordination complexes. II. Effect of the nature and location of ligands in the first platinum coordination sphere].
    Kas'ianenko NA; Karymov MA; D'iachenko SA; Smorygo NA; Frisman EV
    Mol Biol (Mosk); 1995; 29(3):585-96. PubMed ID: 8552062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y; Khokhar AR; al-Baker S; Siddik ZH
    Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo DNA-protein cross-linking by cis- and trans-diamminedichloroplatinum(II).
    Olinski R; Wedrychowski A; Schmidt WN; Briggs RC; Hnilica LS
    Cancer Res; 1987 Jan; 47(1):201-5. PubMed ID: 2431763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous degradation of DNA and chromatin in rat liver nuclei after in vivo treatment with cis- and trans-diamminedichloroplatinum (II).
    Ganeva R; Kokileva L
    Cytobios; 1990; 62(250-251):167-74. PubMed ID: 2171880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells.
    Waud WR
    Cancer Res; 1987 Dec; 47(24 Pt 1):6549-55. PubMed ID: 3677093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water soluble cationic trans-platinum complexes which induce programmed cell death in the protozoan parasite Leishmania infantum.
    Nguewa PA; Fuertes MA; Iborra S; Najajreh Y; Gibson D; Martínez E; Alonso C; Pérez JM
    J Inorg Biochem; 2005 Mar; 99(3):727-36. PubMed ID: 15708793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of the products resulting from the reaction of cis and trans diaminedichloroplatinum [II] with DNA and chromatin on the Dowex 50 W column.
    Oliński R; Walter Z
    Z Naturforsch C Biosci; 1984; 39(11-12):1057-62. PubMed ID: 6543411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of pre-mRNA splicing by cisplatin and platinum analogs.
    Schmittgen TD; Ju JF; Danenberg KD; Danenberg PV
    Int J Oncol; 2003 Sep; 23(3):785-9. PubMed ID: 12888918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interactions of a DNA molecule with coordination compounds of platinum and cobalt in solutions].
    Kas'ianenko NA; Bogdanov AA; Defrenne C
    Biofizika; 2002; 47(3):449-52. PubMed ID: 12068600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theoretical analysis on the transition state of the anticancer drug trans-[PtCl2(isopropylamine)2] and its cis isomer binding to DNA purine bases.
    Zhou L
    J Phys Chem B; 2009 Feb; 113(7):2110-27. PubMed ID: 19173577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of two second generation platinum antitumor drugs with mouse thymocytes.
    Simpkins H; Pearlman LF
    Cancer Res; 1986 Mar; 46(3):1433-9. PubMed ID: 3510724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.